Recognizing these distinctions can help inform evaluation of available options
Nowadays, LY3502790 and PF-06882961 (231233), a class of oral non-peptide small molecule GLP-1RAs with preferable efficacy and anti-diabetes potential, are at the stage of pre-clinical research
The carbohydrate restriction of ketogenic diets further reduces glucose availability, potentially necessitating medication adjustments
For many individuals this may be challenging, so supplementing with whole-foods sources of fiber, including apple pectin, oat fiber, beet fiber, carrot fiber and psyllium husk can help address gaps in dietary fiber intake
2017;53(2):S13142
Our law firm can represent West Virginia patients in Zepbound lawsuits that involve the GIP and GLP-1 products listed above